iShares Core High Dividend ETF vs Humana Inc — how do they compare? iShares Core High Dividend ETF trades at $28.23, while Humana Inc trades at $402.89 (market cap $47.81B). The key difference: Humana Inc pays a 0.89% dividend while iShares Core High Dividend ETF pays none. Which is the better fit depends on your goals.
| HDV | HUM | |
|---|---|---|
52-Week High | $28.36 | $409.42 |
52-Week Low | $23.64 | $163.67 |
Market Cap | — | $47.81B |
Sector | — | Health |
Enterprise Value | — | $56.85B |
Dividend Yield | — | 0.89% |
Signals from Pluang's Aura AI — not financial advice
HDV trades at $28.18, down 0.25% on the day, with technical indicators showing a bullish trend supported by moving averages. Recent corporate actions include a 1:5 stock split in April 2026 and scheduled dividends for mid-2026. The ETF focuses on high-quality, high-yield U.S. large-cap value stocks, emphasizing defensive sectors like healthcare and energy.
Outlook remains positive due to strong technical momentum and quality screening, but risks include sector concentration in energy, which may introduce volatility. The ETF's low beta and focus on dividend sustainability appeal to income-focused investors, though competition from lower-cost alternatives like SCHD warrants monitoring.
Humana (HUM) trades at $404.80, up 1.2% on the day, with a bullish technical signal and recent earnings beats. Revenue has grown steadily to $129.66 billion in 2025, though net income margin has compressed to 0.82%. The company is focused on margin recovery in its Medicare Advantage business and expanding its CenterWell healthcare services segment.
The stock faces headwinds from declining profitability and regulatory scrutiny, but analyst consensus leans Hold with a $354.33 price target below the current price. Upside depends on successful execution of its 2028 margin targets, while risks include healthcare cost pressures and potential legal challenges.
Trailing returns across standard periods
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →